[go: up one dir, main page]

DK3258920T3 - Fast farmaceutisk doseringsform, der er egnet til anvendelse som drikkevandsmedikament - Google Patents

Fast farmaceutisk doseringsform, der er egnet til anvendelse som drikkevandsmedikament Download PDF

Info

Publication number
DK3258920T3
DK3258920T3 DK16706563.0T DK16706563T DK3258920T3 DK 3258920 T3 DK3258920 T3 DK 3258920T3 DK 16706563 T DK16706563 T DK 16706563T DK 3258920 T3 DK3258920 T3 DK 3258920T3
Authority
DK
Denmark
Prior art keywords
dosage form
drinking water
pharmaceutical dosage
form suitable
solid pharmaceutical
Prior art date
Application number
DK16706563.0T
Other languages
English (en)
Inventor
Jean-Paul Remon
Chris Vervaet
Brenda Vermeulen
Original Assignee
Univ Gent
Orotech Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Gent, Orotech Nv filed Critical Univ Gent
Application granted granted Critical
Publication of DK3258920T3 publication Critical patent/DK3258920T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • A23K20/121Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/163Sugars; Polysaccharides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/195Antibiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/10Feeding-stuffs specially adapted for particular animals for ruminants
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/30Feeding-stuffs specially adapted for particular animals for swines
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/70Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75Feeding-stuffs specially adapted for particular animals for birds for poultry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK16706563.0T 2015-02-17 2016-02-17 Fast farmaceutisk doseringsform, der er egnet til anvendelse som drikkevandsmedikament DK3258920T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15155358 2015-02-17
PCT/EP2016/053323 WO2016131853A1 (en) 2015-02-17 2016-02-17 Solid pharmaceutical dosage form suitable for use as drinking water medication

Publications (1)

Publication Number Publication Date
DK3258920T3 true DK3258920T3 (da) 2023-07-03

Family

ID=52573603

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16706563.0T DK3258920T3 (da) 2015-02-17 2016-02-17 Fast farmaceutisk doseringsform, der er egnet til anvendelse som drikkevandsmedikament

Country Status (14)

Country Link
US (1) US10335371B2 (da)
EP (1) EP3258920B1 (da)
AU (1) AU2016221774B2 (da)
DK (1) DK3258920T3 (da)
ES (1) ES2948806T3 (da)
FI (1) FI3258920T3 (da)
HR (1) HRP20230615T1 (da)
HU (1) HUE062147T2 (da)
LT (1) LT3258920T (da)
PL (1) PL3258920T3 (da)
PT (1) PT3258920T (da)
RS (1) RS64306B1 (da)
SI (1) SI3258920T1 (da)
WO (1) WO2016131853A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3578181A1 (en) * 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies
GB201903406D0 (en) * 2019-03-13 2019-04-24 Certis Europe Bv Composition
CN113853425A (zh) 2019-06-21 2021-12-28 埃科莱布美国股份有限公司 固化非离子表面活性剂
CN117599069A (zh) * 2023-12-15 2024-02-27 江苏福润德科技有限公司 复方磺胺嘧啶混悬液的生产工艺
CN118141954B (zh) * 2024-05-09 2024-07-12 四川育强本草生物技术有限公司 一种猴耳环可溶性粉剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK546289D0 (da) * 1989-11-02 1989-11-02 Danochemo As Carotenoidpulvere
AUPM430894A0 (en) * 1994-03-08 1994-03-31 Eli Lilly And Company A formulation and methods of treatment (1)
KR20030078871A (ko) 2000-12-19 2003-10-08 일라이 릴리 앤드 캄파니 이오노포어 항생물질 제제
DE10153934A1 (de) * 2001-11-06 2003-05-22 Basf Ag Verfahren zur Kristallisation von Profenen
GB0205253D0 (en) 2002-03-06 2002-04-17 Univ Gent Immediate release pharmaceutical granule compositions and a continuous process for making them
US20030175333A1 (en) 2002-03-06 2003-09-18 Adi Shefer Invisible patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients onto the skin
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
GB0612695D0 (en) 2006-06-27 2006-08-09 Univ Gent Process for preparing a solid dosage form
FR2910323A1 (fr) * 2006-12-26 2008-06-27 Virbac Sa Sa Composition liquide anhydre destinee a etre incorporee a l'eau de boisson des animaux d'elevage.
US20110294864A1 (en) * 2009-01-13 2011-12-01 Universiteit Gent Aqueous coacervate compositions suitable for making powders and water-soluble formulations of biologically-active agents
GB0900473D0 (en) 2009-01-13 2009-02-11 Univ Gent Aqueous coacervate compositions suitable for making powders and water-soluble formulations of biologically-active agents
WO2013147618A1 (en) * 2012-03-26 2013-10-03 Donaghys Industries Limited Ionophore antibiotic suspension

Also Published As

Publication number Publication date
WO2016131853A1 (en) 2016-08-25
AU2016221774B2 (en) 2020-09-17
US20180064650A1 (en) 2018-03-08
PT3258920T (pt) 2023-07-03
EP3258920A1 (en) 2017-12-27
HUE062147T2 (hu) 2023-10-28
ES2948806T3 (es) 2023-09-19
EP3258920B1 (en) 2023-03-29
AU2016221774A1 (en) 2017-10-05
HRP20230615T1 (hr) 2023-09-29
SI3258920T1 (sl) 2023-10-30
FI3258920T3 (fi) 2023-06-28
LT3258920T (lt) 2023-07-25
RS64306B1 (sr) 2023-07-31
US10335371B2 (en) 2019-07-02
PL3258920T3 (pl) 2023-10-23

Similar Documents

Publication Publication Date Title
DK3236943T3 (da) Sammensætninger til ileo-jejunal lægemiddeladministration
EP4008319C0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING MELOXICAM
DK3341024T3 (da) Væskeformige farmaceutiske sammensætninger, som omfatter sglt-2-hæmmere
BR112017004612A2 (pt) compostos, composição farmacêutica, usos de um composto, e kit
DK3229810T3 (da) Phospholipid-ether-analoger som kræftrammende lægemiddelvehikler
CL2016002569A1 (es) Anticuerpos, composiciones farmacéuticas y usos de los mismos
BR112016023628A2 (pt) composições farmacêuticas.
DK3253382T3 (da) Farmaceutiske sammensætninger til kombinationsterapi
DK3479819T5 (da) Stabilt væskeformigt farmaceutisk præparat
BR112016018062A2 (pt) compostos terapêuticos, composição farmacêutica e usos
BR112016026879A2 (pt) Composição farmacêutica líquida
HK1244691A1 (zh) 用於施用於粘膜的藥物劑型
DK3237045T3 (da) Indretning til indgivelse af lægemidler
HUE050779T2 (hu) Folyékony gyógyszerészeti készítmény
BR112017013012A2 (pt) compostos de indenil, composições farmacêuticas e usos médicos destes
DK3199175T3 (da) Farmaceutisk sammensætning til injektion
DK3258920T3 (da) Fast farmaceutisk doseringsform, der er egnet til anvendelse som drikkevandsmedikament
DK3107526T3 (da) Topisk vandfri fyldformulering til ultravioletfiltre
DK3157506T3 (da) Smagsmaskeret oral, farmaceutisk sammensætning
HRP20181406T1 (hr) Farmaceutski dozni oblici
DK3290023T3 (da) Farmaceutisk sammensætning med langvarig frigivelse, som indeholder rivastigmin
LT3244889T (lt) Farmacinė kompozicija, skirta mikozės gydymui
DK2915526T3 (da) Farmaceutiske sammensætninger, der omfatter anagrelid
DK3270923T3 (da) Terapeutisk middel til frontallapsdysfunktion
DK3157350T3 (da) Doseringshældeanordning til fedtholdige substanser, navnlig til chokolade